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Article 2

Scientists Pinpoint aProtein Critical to the Function ofthe Ebola Virus
By Steven Bradt
cientists at the University of Pennsylva
nia's School of Veterinary Medicine have
identified a sequence of just four amino
acids in a key viral protein that may be critical
to the spread of the Ebola virus. Their findings,
reported in the Dec. 5 issue of the Proceedings
ofthe National Academy ofSciences, offer the
promise of future treatments for Ebola out
breaks that prove fatal for up to 90 percent of
victims.
Ebola hemorrhagic fever is one of the most
dangerous and ghastly viral diseases known to
humans, but much about the underlying virus
continues to elude researchers, said lead author
Ronald N. Harty, Ph.D, assistant professor of
microbiology. Like all viruses, Ebola requires a
host in order to replicate, invading host cells
and using them as factories to crank out
countless copies of its own genetic material.
Harty's work indicates that after this newly
created RNA is packaged into viral protein
coats, the newborn viruses rely on the little
known VP40 protein to traverse the cell's
membrane, exiting the cell by simply budding
off from it. These viruses proceed to infect
other host cells until the cumulative effect of
this explosive viral proliferation overwhelms
the body.
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The function ofVP40, found directly under
the virus's external coat, had previously been
unknown. Harty worked with the isolated pro
tein and single mammalian cells to discover
that a short segment ofVP40 appears to be
what enables Ebola to slip out of host cells.
"This new understanding of the role VP40
plays in Ebola's replication cycle could be a
critical first step in the development of new
antiviral drugs to combat Ebola;' said Harty.
"Now that we've identified this vital region of
this key protein, we may have a target for new
Ebola-fighting medications:'
Because Ebola hemorrhagic fever occurs
only in relatively small, sporadic outbreaks,
Harty said antiviral drugs represent a logical
approach to controlling the disease. There is
currently no specific treatment other than the
administration of intravenous fluids to combat
severe dehydration.
Harty's findings implicate a proline-rich
sequence of amino acids within VP40 as the
key to its ability to bud efficiently from cell
membranes. This segment of the protein 
dubbed a PPxY motif because of its signature
sequence of two prolines (P) and a tyrosine
(Y) separated by any single amino acid - inter
acts physically and functionally with cell
enzymes known as ubiquitin ligases. Such a
virus-host interaction is thought to be crucial

On the cover
Linda, a 13 year old African elephant,
was seen at New Bolton Center for diag
nostic radiographs of her leg. To keep
her content, her two constant compan
ions, Shanna, a 17 year old African ele
phant, and Cora, a 44 year old Asian ele
phant, accompanied her. All three went
to radiology, and the two older ones
watched while technicians took the radi
ographs of the younger elephant's leg.
Once the procedure was complete the
"family group" walked back to the trailer
in a line, trunks holding tails.
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for the virus to escape from the cell.
One of just seven proteins produced by
Ebola, VP40 was significantly impaired in its
ability to exit mammalian cells by even the
slightest mutations affecting the PPxY motif,
Harty found.
"Motifs similar or identical to PPxY are also
common in other viruses, including HN and
the virus responsible for rabies;' Harty said. "In
each case, they function in virus release from
infected cells, and they may carry out this func
tion by mediating interactions with host cell
proteins."
Harty was joined in the research by Melissa
E. Brown and Felicia P. Hayes at Penn and by
Guangli Wang and Jon Huibregtse at the
University of Texas at Austin. The work was
funded by the University of Pennsylvania
Research Foundation.

About Eboia hemorrhagicfever
World Health Organization statistics
indicate that Ebola hemorrhagic fever has
killed 793 of 1,100 known victims since it
was first identified in Sudan and Zaire in
1976. Ebola is believed to originate in the
jungles of Africa and Asia, although it's not
known where, how or in what carrier
species the virus lies dormant between
outbreaks.
Ebola is transmitted through close
contact with bodily fluids, such as mucus,
saliva and blood. Ebola hemorrhagic fever
can take days or weeks to incubate, mani
festing itself only with the sudden onset of
fever, weakness, muscle pain, headache
and sore throat, followed by vomiting,
diarrhea, rashes and reduced kidney and
liver functions. Later, victims start to hem
orrhage and bleed through the nose,
mouth, eyes and other orifices. Blood and
other bodily fluids also begin seeping
through the skin, producing painful
blisters.
The last major Ebola outbreak was in
1995 in Zaire, with as many as 300 lives
lost; the most recent outbreak, in Uganda,
killed more than 100 people several
months ago. Because the virus typically
kills its victims faster than it can spread,
outbreaks have usually been extinguished
before spreading very far.
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